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I GENETIC NATURE OF NEOPLASIA
R. BASERGA, Temple University School of
Medicine, Philadelphia, Pennsylvania 19140,
U.S.A. (Searle Lecturer).
NUCLEAR CONTROL OF CELL PROLIFERATION.
J. CAIRNS, Imperial Cancer Research Fund,
Burtonhole Lane, London NW7.
A PROMOTIONAL MODEL FOR THE PRODUCTION
OF LUNG CANCER BY SMOKING.
J. F. WATKINS, Department of Medical
Microbiology, Welsh National School of Medi-
cine, University of Wales, Heath Park, Cardiff
CF4 4XN.
THE ROLE OF CELL LINES DERIVED FROM
HUMAN TIUMOURS IN THE STUDY OF NEOPLASIA.
II NEOPLASIA AND CYTODIFFEREN-
TIATION
L. G. LAJTHA, Paterson Laboratories, Christie
Hospital and Holt Radium Institute, Man-
chester M20 9BX.
PROLIFERATION CONTROL IN HAEMOPOIESIS.
P. R. HARRISON, Wolfson Laboratory for
Molecular Pathology, The Beatson Institute for
Cancer Research, Garscube Estate, Bearsden
Road, Glasgow C61.
ANALYSIS OF ERYTHROPOIESIS AT THE MOLECUT-
LAR LEVEL.
M. J. EVANS, Department of Anatomy and
Embryology, Unirersity College London, Lon-
don WC1E 6BT.
CYTODIFFERENTIATION OF TERATOCARCINOMA
CELLS.
III NEOPLASTIC TRANSFORMATION
R. DULBECCO, Imperial Cancer Research
Fund,P.O. Box 123, Lincoln's Inn Fields,
London WC2A 3PX.
VIRAL ROLE IN CELL TRANSFORMATION BY THE
SMALL DNA-CONTAINING VIRUSES, POLYOMA
AND SV40.
R. WEISS, Imperial Cancet Research Fund,
P.O. Box 123, Lincoln's Inn Fields, London
WC2A 3PX.
THE ONCOGENE CONCEPT.
H. ROZENGURT, M. GRIMALDI and H. BOURNE,
Imperial Cancer Research Fund, P.O. Box 123,
Lincoln's Inn Fields, London WC2A 3PX.
AN 18,000 K-POLYPEPTIDE INDUCES EARLY
EVENTS AND STIMULATES DNA SYNTHESIS IN
CULTURED CELLS.
IV MEMBRANE DIFFERENTIATION,
CELL SURFACE ANTIGENS AND
RECEPTOR SITES IN NEOPLASIA
R. W. STODDART, Strangeuays Research
Laboratory, Wort's Causeway, Cambridge
CB1 4RN.
MODIFICATIONS OF MEMBRANE GLYCOPROTEIN
IN NEOPLASTIC DISEASE.
M. J. EMBLETON, Cancer Research Campaign
Laboratories, Utiversity of Nottingham, Uni-
versity Park, Nottingham NG7 2RD.
CELL-SURFACE ANTIGENS ASSOCIATED WITH
CHEMICALLY TRANSFORMED CELLS.
V CELLULAR AND HUMORAL
RESPONSES IN NEOPLASIA
G. KLEIN, Department of Tumor Biology,
Karolinska Institute, S 104 01 Stockholm 60,
Sweden.
CELLULAR AND HUMORAL IMMUNE REACTIONS
IN RELATION TO THE THREE EPSTEIN-BARR
VIRUS (EBV) ASSOCIATED HUMAN DISEASES
(MONONUCLEOSIS, BURKITT'S LYMPHOMA AND
NASOPHARYNGEAL CARCINOMA).
N. A. MITCHISON, Imperial Cancer Research
Fund, Tumour Immunology Unit, P.O. Box
123, Lincoln's InnFields, London WC2A 3PX.
REGULATION OF THE IMMUNE RESPONSE TO
CELL SURFACE ANTIGENS.
A. C. ALLISON, J. FERLUGA and H. U.
SCHORLEMMER, Clinical Research Centre,
Watford Road, Harrow, Middlesex HAl 3UJ.
LYMPHOCYTES AND MACROPHAGES IN ANTI-
TUMOUR IMMUNITY.
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ABSTRACTS OF MEMBERS' PROFFERED PAPERS
LETHAL RESPONSE TO DNA-
DAMAGING AGENTS IN A VARIETY
OF HUMAN FIBROBLAST CELL
STRAINS. C. F. ARLETT, MRC Cell
Mutation Unit, University of Sussex, Falmer,
Brighton, BNl 9QG.
Human syndromes such as xeroderma
pigmentosum (XP) and ataxia telangiectasia
(AT) exhibit mutagen sensitivity at the level
of the whole animal and at the cellular level.
In the case ofXP, at least 5 complementation
groups have been observed for the known
defect in excision repair of DNA lesions
induced by UV light. The excision-profi-
cient XPs (variants) have a defect in post-
replication repair. At least 3 classes of
AT cells, all sensitive to y irradiation, are
known. There are those without and those
with an endonuclease defect. Amongst the
latter, two complementation groups have
been observed.
The cross-sensitivity pattern for cell
survival for cell strains from AT, XP, a sun-
sensitive child (11961), Fanconi's anaemia and
progeria is shown in the Table.
RADIOSENSITIVITY IN ATAXIA
TELANGIECTASIA. A. M. R. TAYLOR,
J. A. METCALFE, J. M. OXFORD and D. G.
HARNDEN, Department of Cancer Studies, The
Medical School, University of Birmingham,
Birmingham B15 2TJ.
Patients with the recessively inherited
syndrome ataxia telangiectasia (AT) show a
high incidence of malignant disease, particu-
larly of the reticuloendothelial system. This
susceptibility may be related to the occur-
rence ofspontaneous chromosome aberrations
also seen in these patients. A recently con-
firmed clinical finding has been the unusual
sensitivity to ionizing radiation of these
patients (Cunliffe et al. (1975) Br. J. Radiol.,
48, 374). Cell survival studies on AT skin
fibroblasts following exposure to y-rays and
the effects of X-rays on lymphocyte chromo-
somes have shown that the radiosensitivity
can be observed at the cellular level (Taylor
et al. (1975) ,Nature, 258, 427, and (1976)
Nature, 260, 441). Results from the cyto-
genetic work, together with in vitro enzymatic
assay work (Paterson et al. (1976) Nlature, 260,
LBLE
Cell strain 254 nm 310 nm NHAAF EMS GAMMA MITO-C MMS
Xeroderma pigmentosum + - - + + - - -
XP variant +
11961 -- +- -_-4 _ _
Ataxia telangiectasia
Fanconi's anaemia
Progeria
The results indicate that:
(1) There is no overlap for cell killing between
XP and AT, and that therefore their
endonucleases are distinctive.
(2) 11961 with no known repair defect is
NOT xeroderma pigmentosum (possibly
Cockayne's syndrome).
(3) The limited overlap suggests: (a) dif-
ferent repair modes for each type of
lesion; therefore normal individuals have
a variety of repair capacities; (b) cell
strains available to detect specific classes
of DNA-damaging agents.
444) are consistent with the hypothesis that
there is in AT a defect in the repair of bases
damaged by ionizing radiation.
DNA REPAIR AND MUTAGENESIS IN
MAMMALIAN CELLS. M. Fox, Paterson
Laboratories, Christie Hospital and Holt
Radium Institute, Manchester M20 9BX.
Considerable evidence now suggests that
mutations to resistance to 8-azaguanine or 6-
thioguanine are in the structural gene for
HGPRT, when selection is under well-
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defined conditions. Linear dose-response re-
lationships have been demonstrated for
induced mutation in V79 cells. Both strong
and weak carcinogens are mutagenic, but
mutagenic potency expressed in terms of
mutants induced/lethal hit cannot be corre-
lated directly with carcinogenicity. Studies
on cell lines of different sensitivity to cell
killing, and use of the repair inhibitor
caffeine, have provided evidence for a
caffeine-insensitive " error prone " repair
process in human and rodent cells. This
process appears to operate on a wide range of
DNA lesions (possibly those causing a similar
amount of helical distortion). Thus we
conclude that mutagenesis in mammalian
cells is a consequence of " repair errors " and
is largely independent of the detailed chemi-
cal nature of the DNA lesion.
EFFECT OF DIMETHYLNITROS-
AMINE ON DNA REPLICATION AND
DNA POLYMERASE IN LIVER RE-
GENERATING AFTER PARTIAL
HEPATECTOMY. V. M. CRADDOCK,
MRC Toxicology Unit, Medical Research
Council Laboratories, Woodmansterne Road,
Carshalton, Surrey SM5 4EF.
A single treatment with DMN induces
hepatocellular carcinoma, if given to adult
rats during the period of restorative hyper-
plasia following partial hepatectomy, but not
when given to intact animals. Tumour
incidence is higher when DMN is given during
the period of maximum DNA synthesis (at
24 h) than when given in the pre-replicative
stage (at 6 h). Hence it appeared possible
that replication of DNA damaged by the
carcinogen could be a relevant event in
initiation of cancer.
DNA replication in vivo was measured
after administration of DMN at 6 h or at
24 h. Although DMN caused a dose-depen-
dent inhibition of synthesis, more replication
occurred during the period when methylated
bases formed by reaction with the carcinogen
were known to be present in DNA, when
treatment was at 24 h than at 6 h. DMN
given at 6 h resulted in a dose-dependent
inhibition of induction of DNA polymerase,
assayed in vitro. Parallel experiments were
carried out with MMS, a non-hepatocarcino-
genic methylating agent. The results sug-
gest that when methylating agents are given
17
early in the pre-replicative stage, damage to
DNA inhibits induction of polymerase, and
therefore extensive replication of DNA can-
not occur until the damage has been repaired.
When the alkylating agents are given at 24 h,
by which time DNA polymerase has already
been induced, theenzyme isnot inhibited, and
replication of changed DNA is likely to take
place.
SPONTANEOUS AND INDUCED
PATTERNS OF THE EPSTEIN-BARR
VIRUS (EBV) CYCLE IN HUMAN
LYMPHOMA CELL LINES AND THEIR
SOMATIC CELL HYBRIDS. G. B.
CLEMENTS and G. KLEIN, Department of
Pathology, University of Glasgow, Western
Infirmary, Glasgow GIl 6NT and Department
of Tumor Biology, Karolinska Institute,
S-10401 Stockholm 60, Sweden.
Regulation of the expression of early
antigen (EA) and virus capsid antigen (VCA)
both spontaneously and after treatment with
iododeoxyuridine (IUDR) or P3HR-l-virus
were studied in two somatic cell hybrids
betweenhumanlymphomalines. Thehybrid
8A was derived from crossing the non-
producer Raji with the spontaneous producer
Daudi. The second hybrid, 83, was pro-
duced by fusing Raji with the EBV-genome-
negative B-Lymphoma line BJAB.
The studies indicate that:
1. Spontaneous production of EA and
VCA is regulated by controls differing from
those of P3HR-1 virus or IUDR-induced EA
synthesis.
2. EA and VCA have independent restric-
tion mechanisms, although EA production is
required for VCA synthesis.
3. Inducibility ofEAsynthesisbyP3HR-I
virus and by IUDR appear to be under the
influence of at least partially identical
controls.
This system provides evidence about the
nature of the precise regulatory mechanisms
characteristic of individual cell lines that
control expression of EBV-specified genetic
information in human lymphoma cells.
EBV DNA (usually multiple copies per cell) is
present in virtually all established human
lymphoblastoid and lymphoma cell lines and
also in the tumour cells of nasopharyngeal
carcinoma and most cases of Burkitt's
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lymphoma. The use of somatic cell hybrids
provides an avenue by which the relationship
between the presence in a cell of EBV-
specified genetic information and malignancy
may be investigated.
THE EFFECT OF ALKYLATING
AGENTS ON NUCLEAR POLY (ADP-
RIBOSE) METABOLISM. M. I. DAVIES,
H. HALLDORSSON, S. SHALL and G. J. SKID-
MORE, Biochemistry Laboratory, School of
Biological Sciences, University of Sussex,
Brighton BN1 9QG.
Several alkylating agents, particularly the
substituted nitrosoureas, are used as anti-
tumour drugs. These compounds have, in
addition, mutagenic and carcinogenic activity.
Decreases in the levels of the coenzyme NAD
have been noted in animals treated with these
drugs. Whether this is due to decreased bio-
synthesis or to increased degradation is
unclear.
We have examined the response of NAD
metabolism in mouse leukaemia cells to a
toxic dose of streptozotocin-the glucose
derivative of N-methyl-N-nitrosourea. The
NAD level drops rapidly to 50°/% of control in
4 h, rising again to regain control levels after
8-12 h. The transience of the effect seems
chiefly due to the instability of the drug in
aqueous solution. The effect is not due to
metabolites, for example cyanates, generated
in the medium.
The cellular levels of NAD in L1210
leukaemia cells can be lowered to 10% of
normal without loss of viability, by growing
the cells in nicotinamide-free medium. The
drop in NAD level is not the cause of the
cytotoxicity.
Nicotinamide administered with strepto-
zotocin will prevent the drop in cellular NAD
level, but so will 5-methylnicotinamide and
theophylline, which are not precursors of
NAD. These latter are competitive inhibi-
tors of poly(ADP-ribose) polymerase, the
major enzyme of NAD degradation. Addi-
tion of the inhibitors actually increases the
cytotoxicity of streptozotocin.
We suggest that some of the cytotoxic
effects of alkylating agents are mediated
by effects on chromatin-bound poly(ADP-
ribose).
CYTODIFFERENTIATION IN HUMAN
ACUTE MYELOBLASTIC LEUKAE-
MIA. S. LAN, E. A. MCCULLOCH and J. E.
TILL, Ontario Cancer Institute, Toronto,
Canada.
A procedure for establishing lineage rela-
tionships in haemopoietic differentiation is to
measure correlation coefficients between dif-
ferent cell classes in clonal populations.
Acute myeloblastic leukaemia (AML) can be
regarded as a " clonal haemopathy ", arising
from a neoplastic pluripotent stem cell.
Thus the haemopoietic population in each
patient can serve as a clone in which to
measure such correlations. For this purpose,
in addition to morphologically recognizable
cells, a number of early precursors have been
identified by developmental assays using cell
cultures. For erythropoiesis, these include
erythropoietin-dependent burst-forming units
(BFU-E) recognized by the formation of
large erythroid growth units after 14 days in
culture, and erythropoietin-dependent colony-
forming units (CFU-E) assayed by colony
counts on Day 7. For granulopoiesis, pro-
genitors (CFU-C) are assayed by granulo-
poietic colony formation dependent on
appropriate stimulating molecules. In 22
marrow specimens from 16 patients with
AML, significant correlations were observed
as follows: BFU-E vs CFU-E (P < 0.001);
BFU-E vs platelets (P < 0 01); BFU-E vs
CFU-C (P < 0.01). No significant correla-
tion was observed between the BFU-E,
CFU-E or CFU-C and erythroblasts or
granulocytes. Such data suggest that tests
for correlations may be used to investigate
cell lineage relationships in AML, and predict
that numbers of pluripotent leukaemic stem
cells should correlate stronglv with numbers
of closely-related cell classes such as BFU-E
and CFU-C. This approach should be
valuable in the development and validation of
assays for putative pluripotent leukaemic
stem cells.
STUDIES ON IN VITRO DIFFERENTI-
ATION OF ACUTE MYELOGENOUS
LEUKAEMIA CELLS. F. R. BALKWILL
and R. T. D. OLIVER, I.C.R.F. Department of
Medical Onocology, St Bartholomew's Hospital,
London EC1A 7BE.
Peripheral blood and bone marrow cells
from patients with acute myelogenous leu-
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kaemia (AML) show increases in [3H] thymi-
dine (3HThy) incorporation and absolute cell
number, when grown in short-term liquid
culture without the addition of an exogenous
source of stimulating factor. Cultures from
68 out of 78 (87%) AML patients showed
3HThy incorporation greater than 1000 ct/
min/2 x 105 cells after 96 h (range 1500-
46,000 ct/min, mean 10,600). Asimilarrange
was also seen in bone marrow cultures from
31 patients (mean 11,330) and there was a
good correlation betweenperipheral blood and
bone marrow results. In contrast, studies on
peripheral blood cells from patients with
acute lymphoblastic leukaemia (ALL) showed
significantly less incorporation (mean 1600 ct/
min: n = 16) though this was higher than
that of normal peripheral blood (mean
110 ct/min: n = 4). Detailed morphological
studies demonstrated wide variation from
patient to patient. 80% ofcultures develop-
ed plastic-adherent trypsin-resistant fusiform
cells, with functional surface membrane and
cytochemical characteristics of macrophages.
Time-course studies demonstrated that these
cells were derived by differentiation in vitro
from more primitive precursor cells. Quanti-
tative assessment of the capacity for AML
cells to differentiate into macrophages in
83 patients was shown to be a strong indicator
of response to treatment.
Detailed investigation, using specific
monocyte and granulocyte cytochemical
stains on 15-day cultures from 24 patieDts,
showed evidence of monocyte differentiation
in 16/24 patients, though 7 of these showed
evidence of both monocyte and granulocyte
differentiation, suggesting either duoclonality
or initiation of the disease in a common stem
cell. A further 4 cultures showed evidence of
granulocyte differentiation alone, and 4 no
evidence of either monocyte or granulocyte
differentiation. This extreme heterogeneity
makes it extremely unlikely that a unitary
hypothesis could explain the pathogenesis of
this disease.
APPEARANCE OF ABNORMAL
CHROMOSOMES ASSOCIATED WITH
SPONTANEOUS AND CHEMICALLY
INDUCED TRANSFORMATION OF
CULTURED CHINESE HAMSTER
CELLS. D. J. KIRKLAND and S. VENITT,
Institute of Cancer Research, The Royal
Marsden Hospital, Fulham Road, London
SW3 6JJ.
The chromosomes of cloned Chinese
hamster prostate and kidney cells, and of 10
subclones derived from them, have been
examined for structural and numerical
changes. By standard tissue culture criteria
the 2 parental clones and the 2 subclones were
normal, whereas 8 subclones were trans-
formed, either spontaneously or by chemip.l
induction.
A telocentric chromosome additional to
the diploid complement was found in only 1%
ofthe parental kidney clone, but was found in
over 98% ofthe cells of6 transformed kidney
subclones. One subclone was isolated from
an untreated culture, the others from
3-methyl-cholanthrene-treated culturqs.
Giemsa banding demonstrated this chromo-
some to be the centromere and long (q) arms
ofthe Number 4 chromosome in every case.
A consistent telocentric chromosome,
absent from the parental prostate clone and
2 normal subclones, was found in over 97% of
the cells of 2 transformed subclones isolated
from N-methyl-N-nitrosourea-treated cul-
tures. This chromosome was found to be the
centromere and most of the short (p) arms of
the Number 4 chromosome in every case.
The discovery of specific chromosomal
changes associated with spontaneously or
chemically transformed cells has seldom been
reported. The specific abnormalities report-
ed here might not have been detected had the
cells not been grown in a stabilizing medium
suggested by Yerganian and Lavappa (in A.
Hollaender (Ed.) (1971) Chemical Mutagens,
Principles and Methods for their Detection,
Vol. 2, p. 387, for the maintenance ofChinese
hamster cell karyotypes.
ON THE CRITICAL DIFFERENCE
BETWEEN NORMAL AND CANCER
CELLS, AND THE POSSIBLE ORIGIN
OF THE HAYFLICK LIMIT. R. J.
GOLDACRE, Chester Beatty Research Institute,
Fulham Road, London SW3 6JB.
While it has been widely believed in the
past that cancer is due to mutation, there is
now reason to think that cancer may result
from a process akin to differentiation, i.e.
maldifferentiation. Is the cancer genome
different from the normal? There are no
known general biochemical differences be-
tween normal and cancer cells. Properties
distinguishing cancer cells from correspond-
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ing normal cells (including biochemical and
cell surface changes) can always be matched
singly in some normal cell or other-as if all
these " cancer " properties are needed by
some normal cell during normal life.
It seems as if some intracellular control
mechanisms have been delegated in normal
cells to act between cells, while the cancer cell
has retained them within itself: a process
requiring rearrangement of molecules but not
generation of new ones. This delegation
appears to have a bearing on the Hayflick
limit.
Cancer cells resemble protozoa which can
live independent lives. When metazoa evol-
ved, genetic instructions had to be provided
to the cell to adhere, pass growth-controlling
information from cell to cell, etc. It is likely
that, in mammals, repressed genes still persist
for unicellular life (as persists the genetic
code from that time-the same code for
plants, animals and bacteria). Thus the
opportunity to (mal)differentiate back may
persist. Conversely Papaionnou et al. ((1975)
Nature, 258, 70) have recently reported the
differentiation of genetically marked terato-
carcinoma cells, fused with a blastula, into
normal tissue.
Nuclei were exchanged between 5 dif-
ferent pairs of normal and cancer cells in the
mouse; wherever it has been possible to make
an assessment of malignancy in the resulting
cells, by tumour formation or cell surface
properties, the malignancy corresponded to
that ofthe cytoplasm and not ofthe nucleus.
SELECTIVE INHIBITION OF THE
OUTGROWTH OF EPSTEIN-BARR
VIRUS-CARRYING CELLLINES FROM
LEUCOCYTES OF INFECTIOUS
MONONUCLEOSIS PATIENTS. A. B.
RIcKINsoN and M. A. EPSTEIN, Department of
Pathology, The Medical School, University of
Bristol, Bristol BS8 lTD
The leucocytes of infectious mono-
nucleosis (IM) patients readily gave rise to
Epstein-Barr (EB) virus-genome-containing
lymphoid cell lines in vitro. The view that
the virus-carrying cells in IM blood are actu-
ally transformed by the virus in vivo has
recently been challenged by the observation
that transformed foci arise in IM leucocyte
cultures, not primarily through a process of
direct outgrowth, but by a quite different
two-step mechanism; thus cells harbouring
the virus in vivo enter a productive cycle in
vitro and release virus particles, which then go
on to infect lymphocytes co-resident in the
culture, transforming them into lympho-
blastoid cell lines. The present experiments
seek to determine whether this two-step
mechanism is wholly responsible for the
establishment of cell lines from IM leuco-
cytes, ot whether it serves to mask the direct
in vitro outgrowth of cells already trans-
formed by EB virus in vivo.
The first experiments show that di-
sodium phosphonoacetate (PA), when present
in culture medium at a concentration of
50 ,ug/ml, strongly inhibits the replication of
EB virus in cells of a producer line, but does
not seriously affect either the growth rate of
virally transformed cells, or the transforma-
tion of foetal lymphocytes following their
infection by the virus in vitro. The second
experiments show that when IM leucocytes
are cultured in medium containing 50 ,ug
PA/ml, that is under conditions which selec-
tively block the two-step mechanism, the
establishment ofEB virus-genome-containing
cell lines is abolished. These results confirm
the exclusive role proposed for the two-step
mechanism in the development of such cell
lines, and argue against the existence in IM
blood of cells already transformed by EB
virus and capable of independent in vitro
growth.
STUDIES ON LIVER CHROMATIN
RNA FROM RATS TREATED WITH
NN -DI[14C]METHYLNITROSAMINE.
A. I. GALBRAITH and R. F. ITZHAKI, Paterson
Laboratories, Christie Hospital and Holt
Radium Institute, Manchester M20 9BX.
As part ofa study ofthe effect of carcino-
gensonchromatin (Saffhilletal. (1974)Nature
248, 153; Cooper and Itzhaki (1975) Biochem.
biophys. Acta, 407, 263; Cooper et al. (1975)
Chem. Biol. Interactions, 11, 483) we have
examined the methylation of liver chromatin
RNA after treatment of rats with dimethyl-
nitrosamine. We have previously shown
that the RNA consists ofa stable, low mol. wt
component and a rapidly synthesized com-
ponent ofhighermol. wt, probablycomprising
nascent messenger RNA.
Chromatin was prepared from rat livers
3-72 h after injection ofthe hepatoc.arcinogen
248B.S.C.B. AND B.A.C.R. JOINT AUTUMN MEETING
N,N-di[14C]methylnitrosamine. It was found
that the major methylation product in
the chromatin RNA was 7-methylguanine,
and at 3 h after injection the percentage of
guanine methylated was about 50% higher
than that in the chromatin DNA. In the
next 30 h the RNA methylation decreased
rapidly by 50%, but the subsequent decrease
was lower, values falling byonly 20% per day.
Experiments are now in progress to find
out whether one or both RNA components are
methylated.
CHANGES IN CHINESE HAMSTER
CELLS DURING THEIR PROGRES-
SION IN CULTURE FOLLOWING
CARCINOGEN TREATMENT. J. R.
CONNELL and C. H. OCKEY, Paterson Labora-
tories, Christie Hospital and Holt Radium
Institute, Manchester M20 9BX.
Diploid Chinese hamster cells were treated
at their first passage with the carcinogens BP,
DMBAandMNNG, inDMSO. Controls were
treated with the solvent DMSO alone. A
karyotype study has been maintained as these
cells progress through culture. Changes in
karyotype, cell morphology, ability to growin
soft agar, reaction to cytochalasin B and their
sister-chromatid exchange frequency were
investigated because of their probable associ-
ation with cell transformation in vitro.
From these investigations it appears that
certain chromosomes seem to be generally
involved in karyotype changes in a consecu-
tive sequence as the diploid cells progress
through culture. The onset ofthe karyotype
change is earlier following carcinogen treat-
ment. Although morphological changes, the
ability to grow in soft agar, etc., occur inde-
pendentlyintimesequence oncethekaryotype
is changed, there does not appear to be a
direct relationship in this material between
any obvious specific chromosome change and
the immediate appearance of cell transforma-
tion in vitro.
AN ASSAY FOR CELL INVASIVENESS.
C. TICKLE, A. CRAWLEY and L. WOLPERT,
Department ofBiology as Applied to Medicine,
The Middlesex Hospital Medical School,
London WlP 6DB.
One of the characteristics of cells that
have been transformed in tissue culture by,
for example, certain viruses or X-irradiation
is that the morphology of the culture is
changed, so that cells criss-cross each other
rather than form a monolayer. It has been
suggested that this change in culture mor-
phology reflects an alteration inthe behaviour
oftheindividual cells whentheymake contact
and, byanalogywiththeworkofAbercrombie
and Heaysman on the behaviour of cells
derived from solid tumours in culture, trans-
formed cells have been said to show a loss of
contact inhibition of locomotion. It is this
altered contact behaviour, it has been sug-
gested, that may account for the invasiveness
of cancer cells in vivo. We have been
developing an assay for invasiveness which
involves the grafting of test cells into the
developing chick wing bud. This assay
should enable us to find out whether charac-
teristics ofcancer cells such as lack ofcontact
inhibition of locomotion do in fact lead to
invasive behaviour of two normal cell lines
and their virally transformed derivatives and
also of embryonic heart and sarcoma 180
tumour cells.
ENZYME MARKERS IN TRANSFORM-
ED CELLS. P. D. WILSON, Department of
Cellular Pathology, Imperial Cancer Research
Fund, Lincoln's Inn Ftelds, London
WC2A 3PX.
Many people have been involved in the
search for markers of neoplastic transforma-
tion in vitro. A number of enzyme changes
undoubtedly occur, but these may be purely
theresultofthecultureprocess. Anapparent
levelling out of a variety ofenzyme activities
was demonstrated after short-term culture of
mouse and human embryo tissues. Mito-
chondrial and cell-surface enzymes were
particularly susceptible to change. Certain
enzyme changes have been found to accom-
pany transformation in vitro: in a series of
normal tissues derived from young and old
mice which had undergone spontaneous neo-
plastic transformation in vitro, alkaline phos-
phatase activity was completely lacking.
However, this is by no means a universal
marker of spontaneous virus- or chemical-
carcinogen-induced transformation in vitro
or in vivo. A wide variety of patterns of
enzyme change has been found in different
systems. Within a group of5 established cell
lines, all derived from human bladder
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carcinomas, there were significant variations
in the total activity levels and isoenzyme
patterns of alkaline phosphatase.
MEMBRANE CHANGES OF INVASIVE
HUMAN TRANSITIONAL CARCI-
NOMA CELLS. R. M. HICKS, J. CHOWA-
NIEc and J. NEWMAN, Department of Histo-
pathology, The Middlesex Hospital Medical
School, RidingHouseStreet, London WIP 7LD.
The urothelium of transitional-cell tu-
mours in rat and man is undifferentiated.
The normal polyploid superficial cells, with
their unique surface membrane, are lost and
replaced by smaller cells, whose free surfaces
are covered with microvilli. We have shown
that the membrane limiting the microvilli has
a pronounced glycoprotein surface coat,
which we suggest to be either a tumour-
associated neo-antigen, or the re-expression
in the neoplastic cells of a foetal genome
which is normally repressed in the adult.
Either way, it was puzzling that in experi-
mentally induced rat tumours, which are
usually not aggressively invasive and tend to
have a compact nodular growth pattern, the
glycocalyx was only observed on the urinary
face of the surface and not deeper in the
tumour.
In human urothelial tumours, the cells at
the invading edge tend to have a more dis-
organized growth pattern and develop many
microvillus-like extensions into the surround-
ing connective tissue. Like the cells on the
surface of the tumour, these invasive cells in
the bladder wall have a pronounced surface
coat which is morphologically distinct from
basal lamina or other extracellular material.
This is an important confirmation that the
surface coat is produced by the neoplastic
urothelial cells, and is not simply a condensa-
tion of material from the urine on to the free
epithelial surface.
CARBOHYDRATES ASSOCIATED
WITH SURFACE AND NUCLEAR
MEMBRANES OF NEOPLASTIC
CELLS. M. R. PRICE and R. W. STODDART,
Cancer Research Campaign Laboratories, Uni-
versity of Nottingham, University Park, Not-
tingham NG7 2RD, and Strangeways Research
Laboratory, Worts Causeway, Cambridge
CBI 4RN.
Carbohydrates located at the surface and
nuclear membranes of chemically induced rat
hepatoma and sarcoma cells have been identi-
fied, using purified lectin preparations. For
these studies the following lectins were
employed: concanavalin A (specificity: a-D-
mannose, a-D-glucose), soya bean agglutinin
(specificity: N-acetylgalactosamine) and Rici-
nus communis lectin (specificity: P-D-galac-
tose). Cultured tumour cells were examined
for lectin-induced agglutination, and the
findings were compared with those obtained
using fluorescein-conjugated lectins as mark-
ers for specific carbohydrates in sections of
tumour tissue. The two techniques were
comparable for the detection of lectin recep-
tors and, in cases of positive reactions, these
were specifically inhibited by the addition of
the appropriate monosaccharide. The most
prominent feature in these tests was that rat
tumour cells were characterized by high con-
centrations of terminal D-galactose-like resi-
dues, as revealed by their interaction with
Ricinus communis lectin.
Carbohydrate residues were detected upon
purified nuclei, using fluorescein-conjugated
lectins, although, since a proportion of the
outer nuclear membrane is lost during the
isolation procedure, it is not known to what
extent lectin receptors are associated with the
outer membrane and/or with exposed regions
ofthe inner nuclear membrane.
ESTIMATION OF OESTROGEN
RECEPTORS IN THE NUCLEAR
FRACTION OF MAMMARY TUMOUR
BIOPSIES. L. LAING and R. LEAKE,
Department of Biochemistry, University of
Glasgow, Glasgow 012 8QQ.
Measurement of the number of specific,
high-affinity oestrogen receptors in the cyto-
plasmic fraction of mammary tumour biopsy
specimens has been used to predict whether
or not particular tumours will respond to
hormone therapy or ablation. Results from
several laboratories, including our own, indi-
cate that tumours with receptor concentra-
tions, in excess of 80 fmol/mg cytosol protein
may respond to hormone therapy, whereas
thosewithconcentrations belowthisfigurewill
not. Since only one-third of patients carry
tumours showing this highly elevated level,
two-thirds can be put directly on to alterna-
tive treatment such as chemotherapy, and
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saved the trauma of major surgery. How-
ever, of the one-third of patients who show
appropriately elevated receptor levels, only
two-thirds respond to hormone therapy.
Our results suggest that at least some ofthese
" false positives " arise because the tumours
contain varying levels of abnormal receptor,
which binds [3H] oestradiol with characteristic
high affinity (Kd in range 10-10 to 10-9M) and
specificity, but does not translocate to the
nucleus. We have one patient with markedly
elevated cytoplasmic receptor and normal
plasma oestrogens, but no detectable nuclear
receptor. The percentage of translocatable re-
ceptor in other patients is veryvariable. Endo-
genous nuclear receptor levels are measured
prior to estimation in vitro ofthe ability ofthe
available cytoplasmic receptors to translocate
to the nucleus.
SIMULTANEOUS FLUORESCENCE
ANALYSIS OF PLASMA MEMBRANE
AND DNA IN INDIVIDUAL CELLS
BEFORE AND AFTER TRANSFORMA-
TION. S. P. HAWKES and J. C. BARTHOLO-
MEW, Laboratory of Chemical Biodynamics,
Lawrence Radiation Laboratory, University of
California, Berkeley, California 94720, U.S.A.
Cell-surface labelling with fluorescarnine
indicates that the fluorescence of chick
embryo fibroblasts is decreased by a factor of
three aftertransformation withRSV (Hawkes,
Meehan and Bissell (1976) Biochem. biophys.
Res. Conmm., 68, 1226). A similar difference
has been observed between Balb 3T3 A31
HYF cells and their MSV/MLV-transformed
counterparts. Thisphenomenon enables non-
transformed and transformed cells to be dis-
tinguished by flow microfluorometry. A
technique of double fluorescence labelling has
been developed, to correlate the cell surface
differences with DNA content, by combining
fluorescamine labelling xvith propidium iodide
staining ofDNA. Both fluorofors are excited
by the 351 and 363 nm lines of an argon-ion
laser and the wide spectral separation of the
emission maxima (at least 120 nm) allows
simultaneous DNA and cell surface measure-
ments to be made on each cell. Distribution
during the cell cycle, obtained by electronic
gating of the fluorescamine against the
propidium iodide signal, showed distinct dif-
ferences in the cell-surface fluorescence.
Furthermore, the fluorescamine signal for
both non-transformed and transformed cells
increased as they traversed the cell cycle from
G1. This technique allows dissection of
alterations in the cell surface, both during the
cell cycle and as a consequence oftransforma-
tion. The striking cell-surface difference
offers the possibility of resolving normal and
neoplastic cells in a mixed population.
LYMPHOCYTE SURFACE MARKERS
IN MALIGNANT LYMPHOMAS. S. V.
PAYNE, D. B. JONES, J. L. SMITH and D. H.
WRIGHT, University Department of Pathology,
South Laboratory and Pathology Block, South-
ampton General Hospital, Tremona Road,
Southampton S09 4XY.
Lymphocyte markers were used to identi-
fv the cells in Hodgkin's and non-Hodgkin's
lymphoma biopsy specimens. Malignant
Reed-Sternberg cells and their mononuclear
variants (Hodgkin's cells) had surface charac-
teristics ofB lymphocytes, and also contained
monotypic cytoplasmic immunoglobulin.
The reactive lymphocytes present were pre-
dominantly T cells, and the activated state of
many of them, as well as their attachment to
the surface of the Hodgkin's cells, indicated
that they may be specifically reactive against
the tumour cells. This is of significance to
proposals that a " lymphocyte war " is impli-
cated in the aetiology of Hodgkin's disease
(Payne et al. (1976) Clin. exp. Immunol., 24,
280).
Lymphocyte markers were successful in
identifying a normal counterpart for 22 out of
the 23 non-Hodgkin's lymphomas studied;
20 were derived from B lymphocytes, two
from histiocytes and one was unclassifiable.
The histological evidence that the series of
B-cell lymphomas was reflecting a spectrum
of maturation was confirmed by their pattern
of immunoglobulin staining, but not by the
presence of Fc and C3 receptors. These were
present on tumour cells in most cases, but the
variability in strength of receptors and in the
proportion of tumour cells positive did not
correlate with maturity. With one excep-
tion, between 4%O and 76% of the cells dis-
persed from these biopsy specimens were
T cells. Ofinterest, regarding the possibility
that these T cells were involved in an im-
mune response against the tumour cells, is
their higher incidence in nodular lymphomas,
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which are prognostically more benign than
diffuse types.
DEPRESSION OF MONONUCLEAR
PHAGOCYTE FUNCTION BY LEWIS
LUNG CARCINOMA IN C57BL MICE.
A. A. OTU, R. J. RUSSELL and P. C. WILKIN-
SON, University Department of Bacterwlogy
and Immunology, Western Infirmary, Glasgow
WI.
In the present investigation, the function
ofthemononuclearphagocytesystemhasbeen
measured in control mice and in mice bearing
the Lewis lung carcinoma, a growing and
metastasizing tumour, at various times after
tumour inoculation. The following func-
tions were measured: clearance of colloidal
carbon from the circulation in vivo; chemo-
tactic locomotion of macrophages towards
standard agents in the presence or absence of
sera or tumour supernates from tumour-
bearing mice; and the formation of macro-
phage colonies by bone marrow cells in vitro,
in the presence and absence of sera from
tumour-bearing mice.
Although previous workers (Old et al.
(1961) Cancer Res., 21, 1281; Baum and
Fisher (1972) Cancer Res., 32, 2813), have
observed enhancement ofmononuclear phago-
cyte function in tumour-bearing mice, we
found a very clear depression of macrophage
chemotaxis and macrophage colony forma-
tion in vitro, in the presence of sera or tumour
supernates from tumour-bearing mice, when
these sera or supernates were prepared from
mice 24-72 h after tumour inoculation.
Similarly, tumour-bearing mice showed a
marked depression of carbon clearance in the
first 72 h after tumour inoculation. The
evidence obtained so far suggests that the
depression of mononuclear phagocyte func-
tion in tumour-bearing mice is due to a
tumour-released factor present in serum.
This depression in the early stages after
tumour inoculation may be an important
factor in allowing escape oftumour cells from
host surveillance.
LYMPHOCYTE: TUMOUR CELL
INTERACTION IN ORAL NEOPLASIA.
P. B. NOBLE and K. C. BENTLEY, Faculty of
Denttstry, McGill University, P.O. Box 6070,
Station A, Montreal, Quebec, Canada H3C 3G1.
The presence of mononuclear leucocytes
within tumours is thought to indicate a more
favourable prognosis. It has been well docu-
mentedthat mononuclear leucocytes have the
potential to kill tumour cells. The efficiency
of this process must be dependent on the
mechanisms responsible for bringing these cell
types into close proximity with one another.
Two possibilities exist: first, that mono-
nuclear leucocytes randomly migrate into a
tumour and are stimulated to divide locally
and/or second, that some form of chemotaxis
exists. Using time-lapse cinephotomicro-
scopy, we have devised a technique whereby
the locomotory paths of cells can be charac-
terized and quantitated, which enables this
second possibility to be tested. The loco-
motory paths of cells are modelled by a
continuous-time Markov chain consisting of
5 states; state 0 inwhichthe cell is stationary,
and 4 states whose direction is defined by the
4 quadrants of a cartesian plane. From the
time-lapse films, cell paths are plotted and the
state and time in each state is recorded.
Analysis of these data provides information
characterizing lymphocyte locomotory be-
haviour in the absence and presence of
tumour. Preliminary results suggestpositive
chemotaxis by lymphocytes in early and
regressing lesions, little or random movement
pending pre-malignant change, and negative
chemotaxis during malignant dominance.
Thesefindings, confirmedbyhistopathological
assessment of the degree of lymphocyte
involvement, suggest that dominance of host
defence mechanism may occur because the
tumour can inhibit the host cellular inflam-
matory response.
ANTIGEN EXPRESSION ON CELLS
OF RAT TUMOUR XENOGRAFTS IN
ATHYMIC NUDE MICE. M. V. PIMM,
Cancer Research Campaign Laboratories, Uni-
versity of Nottingham, University Park, Not-
tingham NG7 2RD.
Rat tumour xenografts in athymic nude
mice have been examined for cell-surface
tumour-specific and embryonic antigens
known to be expressed on growths in syn-
geneic animals. In addition, sera of mice
bearing rat tumours have been examined for
anti-rat antibodies and soluble tumour
antigens.
With a 3-methylcholanthrene-induced
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sarcoma (Mc7) and an aminoazo-dye-induced
hepatoma (D23), the individually distinct
tumour-associated antigens expressed on
transplants in syngeneic rats were also
demonstrable on cells from tumour xenografts
in athymic mice, using an indirect membrane
immunofluorescence (MIF) test with rat
tumour-specific antisera. Re-expressed em-
bryonicantigen(s),normallyfoundoncellsfrom
tumoursinsyngeneicrats, werealsodetectable
by reactivityof target cells from growths in
athymic mice with multiparous rat serum.
Mice bearing progressively growing rat
tumour xenografts rarely had detectable
levels of anti-rat antibody. However, sera
from mice with xenografts of rat sarcoma
Mc7 or hepatoma D23 specifically neutralized
reactivity in MIF tests of rat tumour-specific
antisera, indicating the presence in these sera
of soluble tumour-specific antigens.
These studies demonstrate that antigen
expression, both tumour-specific and em-
bryonic, continues in rat tumours xenografted
to athymic mice, and that tumour-associated
antigens may be released into the serum.
LEUCOCYTE MIGRATION INHIBI-
TION BY CANCER PATIENTS' SERA.
A. J. COCHRAN, R. M. MACKIE, C. E. Ross,
L. J. OGG and A. M. JACKSON, Pathology
Department, University of Glasgow, Western
Infirmary, Glasgow Gl1 6NT.
Sera from 38/89 melanoma patients, 4/15
patients with other cancers and 3/43 control
donors inhibited the migration of autologous
leucocytes. Sera from patients with clini-
cally detectable imetastatic disease, and from
the recipients of BCG, were most frequently
inhibitory. Allogeneic sera were also inhibi-
tory, and their activity related to the clinical
status of the serum donor, and not to the
ABO compatibility of leucocytes and serum.
Autologous sera from 31/71 melanoma pati-
ents and 3/31 control donors increased the
leucocyte migration inhibition induced by
formalinized melanoma cells. This activity
occurred in sera from patients at all stages of
malignancy, whether bearing detectable
tumour or not, and whether receiving BCG or
not. Abrogation oftumour-cell-induced leu-
cocyte migration inhibition by serum was less
frequent, occurring with 8/71 melanoma
patients (6 Stage III, 1 Stage I and 1 Stage II)
and no control sera. Preincubation of
formalinized tumour cells had no effect on
their activityintheleucocytemigrationassay,
but the preincubation ofmelanoma or control
leucocytes with either autologous serum or
foetal calfserum inhibitedleucocytereactivity
in approximately 50% of tests. This last
effect appears to be immunologically non-
specific.
SKELETAL METASTASES: RELA-
TIONSHIP OF BONE DESTRUCTION,
OSTEOCLAST ACTIVATION AND
PROSTAGLANDINS. C. S. B. GALASKO
and A. BENNETT, Orthopaedic Unit, Royal
Postgraduate Medical School, Hammersmith
Hospital, London W12 OHS, and Kings
College Hospital, Medical School, Denmark
Hill, London SE5 8RX.
Necropsy and animal experiments indi-
cate that there are two main mechanisms for
the bone destruction associated with skeletal
metastases. The early, and quantitatively
more important mechanism, is mediated via
osteoclasts,thetumoursecreting anosteoclast-
activating factor. This is diffusible, but acts
only locally in the neighbourhood of the
tumour. The second mechanism occurs at a
late stage, when the residual trabecula are
completely surrounded by tumour cells. At
this stage the osteoclasts disappear, although
bone destruction continues.
VX2 carcinoma cells were found to syn-
thesize large amounts ofprostaglandin-E2-like
material, which could be significantly reduced
by pretreating the animal with indomethacin
(2.4 + 0-63 jug equivalent/g reduced to
0-24 ± 015 Itg PGE2 " basal " levels
(P < 0-01); and 4-73 ± 106 ,ug reduced to
0-19 ± 0-07 ,ug " basal + synthesized " levels
(P < 0-01)). Indomethacin pretreatment of
rabbits given an intramedullary injection of
VX2 carcinoma cell suspension reduced
osteoclast proliferation in the neighbourhood
of the tumour (11.1 ± 2-13 osteoclasts re-
duced to 5-2 ± 1-71 osteoclasts (P < 0-05), as
well as the amount of bone destruction.
Since inhibition of osteoclast proliferation
and bone destruction were not complete, non-
prostaglandin materialmight also beinvolved.
The results ofthese studies suggest that if
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indomethacin or similar agents are to have a
clinical role, they will presumably be useful
only in early skeletal metastases associated
with osteoclast activation.
THE EXPRESSION OF THE INTER-
FERON SYSTEM IN CLONES OF
CHINESEHAMSTER/HUMANHYBRID
CELLS. M. J. MORGAN and P. FAIK,
Department of Biochemistry, University of
Leicester, University Road, Leicester LEI 7RH.
The presence of the interferon system has
been investigated in a number ofindependent
hybrid clones derived from a fusion ofChinese
hamster cells (CHO-K1; CCI-61) and normal
human brain cells. Each clone was charac-
terized on the basis of the electrophoretic
mobility of various isozymes, and tested for
the production ofinterferon active in Chinese
hamster cells and/or human foreskin fibro-
blasts, and for the development of virus
resistance in response to Chinese hamster
interferon and human leukocyte interferon.
The results confirm that human chromo-
some 21 is required for the anti-virus effect in
response to human interferon. Human chro-
mosome 5, but not 2, is essential for human
interferon synthesis, and human chromosome
18 may be essential for Chinese hamster inter-
feron synthesis. Only some clones were
sensitive to hamster interferon, but it has not
been possible to correlate this sensitivity with
the presence or absence of a human chromo-
some.
ULTRASTRUCTURAL CHANGES AT
THE EPITHELIAL-MESENCHYMAL
INTERFACE IN EXPERIMENTALLY
INDUCED BLADDER TUMOURS. J.
CHOWANIEc and R. M. HICKS, Department of
Histopathology, The Middlesex Hospital Medi-
cal School, Riding House Street, London
WIP 7LD.
Ultrastructural alterations were observed
at the interface between the neoplastic uro-
thelium and underlying mesenchymal tissues.
These were compared to changes induced by
cyclophosphamide, which is cytotoxic but not
carcinogenic for the urothelium.
Tumours from the bladders of rats sub-
jected to four different experimental treat-
ments were studied by EM. Associated with
these tumours, morphological alterations of
the basal lamina at the epithelial-mesen-
chymal interface, and around blood capillaries
were noted. These included basal lamina
thickening, degeneration or dislocation, and
reduplication or lamination. Observations
also showed extensive destruction of the
underlying collagen, suggesting release of
collagenases by the neoplastic urothelium.
There was also deposition of fibrin in and
around some tumours, possibly due to the
inhibition of tissue plasminogen activators.
These morphological alterations were associ-
ated with progression from in situ papillary
carcinomas to early, locally invasive uro-
thelial cancers. Human biopsy material
from patients with bladder tumours was also
studied for comparison.
Similar changes have been documented
for other neoplastic tissues, particularly
experimentally induced skin tumours in rats,
and human oral cancers.
THE EFFECT OF NICOTINAMIDE ON
THE DEVELOPMENT AND LOCALI-
ZATION OF TUMOURS, AND ON THE
EXCRETION OF PORPHYRINS IN
THE URINE OF RATS GIVEN THE
HEPATOCARCINOGEN, DIETHYL-
NITROSAMINE. S. GIBBARD and R.
SCHOENTAL, Department of Biochemistry,
Princess Alexandra Hospital, Harlow, Middle-
sex, and Department qf Pathology, The Royal
Veterinar?y College, University of London,
Royal College Street, London NW1 OTU.
Pretreatment with nicotinamide can in-
crease the incidence of pancreatic islet-cell
tumours in rats given the carcinogens,
streptozotocin (Rakieten et al. (1971) Proc.
Soc. expt. Biol. Med., 137, 280) and heliotrine
(Schoental (1975) Cancer Res., 35, 2020),
known to deplete NAD coenzymes in the
liver. Similar treatment with nicotinainide
ofrats given diethylnitrosamine increased the
incidence ofkidney tumours; pancreatic islet-
cell adenomas were found only rarely.
The increased excretion of urinary por-
phyrins after diethylnitrosamine was lowered
and delayed in rats pretreated with nicotin-
amide.
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PLASMINOGEN -ACTIVATOR -MEDI-
ATED QUASIMALIGNANT CHARAC-
TERISTICS OF 3T3 CELLS: MOR-
PHOLOGY AND CELL KINETICS. C.
M. URQUHART, E. WRIGHT, P. WHUR, M.
GORDON and D. C. WILLIAMS, Marie Curie
Memorial Foundation, Research Department,
The Chart, Oxted, Surrey, and City of London
Polytechnic.
3T3 cells co-cultured for 24 h with SV40-
3T3 transformants became highly agglutin-
able by concanavalin A. This induced
agglutinability was due to activation ofserum
plasminogen to plasmin by SV40-3T3 acti-
vator. Additional plasmin-mediated effects
have now been sought, using this system.
Subconfluent monolayers of 3T3 cells in co-
culture have altered morphology; the degree
of cell spreading was significantly reduced by
one-third after 3 days in co-culture, and such
cell populations were significantly more
trypsin sensitive. However, no change in cell
growth kinetics has been detected. The
duration of all phases ofthe cell cycle includ-
ing GI was unaltered, and there was no
detectable increase in mitotic index: in con-
confluent cells during the first cycle traverse
in co-culture, when compared to controls in
monoculture. However, in preliminary ex-
periments we have detected significantly
increased levels of [3H]thymidine incorpora-
tion into the acid-insoluble fraction of 3T3
cells during the first few cycles in co-culture.
SURFACE CHANGES IN CHINESE
HAMSTER CELLS DURING THEIR
PROGRESSION IN CULTURE FOL-
LOWING CARCINOGEN TREAT-
MENT. C. J. HARRISON and T. D. ALLEN,
Paterson Laboratories, Christie Hospital and
Holt Radium Institute, Manchester M20 9BX.
Diploid Chinese hamster cells were treated
at their first passage with the carcinogens BP,
DMBA and MNNG, in DMSO. Controls
were treated with the solvent DMSO alone,
and the subsequent changes in cell surface
morphology were investigated.
The control cells initially had a smooth
surface morphology, apart from sparse
extremely short microvilli which increased in
both length and density with increasing cell
passage. Microvillous ridges or " combs "
were formed and also increased in frequency
as the cells progressed.
The BP-treated cells showed a loss of
orientation and began to pile up, 25 passages
aftertreatment. The sametrends, ofincreas-
inglength and microvillous density, and comb
formation, with time were observed, as in the
controls, but to a much greater extent.
No piling up has yet been observed in
either the DMBA- or MNNG-treated cultures.
These showed the same characteristics, with
time in culture, as above. The DMBA cells
maintained a close similarity to the controls
in terms of surface morphology, whilst the
MNNG cultures were comparable to the BP
cells.
It appears therefore that with increasing
passage in culture, important surface mor-
phological changes take place, and that these
are modified by carcinogen treatment.
DEPLETED SURFACE SIALO-PEP-
TIDE IN LEUKAEMIC CELLS. H.
SMYTH and R. O'KENNEDY, Department of
Biochemistry, University College, Belfield,
Dublin 4, Eire.
Surface sialic acids are involved in cellular
interactions, immunogenicityandmalignancy.
Exposure of cells to neuraminidase removes
terminal sialic acid in free form, while proteo-
lysis liberates it as a peptide complex. We
measured peptide-bound sialic acid released
during proteolytic exposure of human peri-
pheral lymphocytes from non-leukaemic and
chronic lymphatic leukaemic (CLL) subjects,
granulocytes from chronic myeloidleukaemics
(CML) and tissue-located lymphocytes from
human tonsils and calfthymus. The proteo-
lytic enzyme used was brinase, which en-
hances human lymphocyte activity in vivo
(Thornes (1974) Lancet, ii, 382).
Non-leukaemic peripheral lymphocytes
liberated 53-5 ± 6-8 nmol peptide-bound si-
alic acid/109 cells (mean + s.e., 6 individuals)
during mild proteolysis in vitro. Values for
leukaemic cells were markedly reduced, viz.:
CLL lymphocytes, 15-8 ± 4.2 (5), P < 001,
and CML granulocytes 12-3 (2). Low levels
were also noted for non-malignant lympho-
cytes oftissue origin, that for human tonsillar
lymphocytes being 15-8 ± 2-0 (12) and that
for calf thymocytes even lower.
The level ofneuraminidase-sensitive sialic
acid is unaltered in CLL cells (Lichtman and
Weed (1970) Blood, 35, 12). Our results
show that the protease-sensitive fraction (ca.
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29%) of this moiety is significantly depleted.
Malignant transformation of tissue culture
cells is associated with disappearance of a
trypsin-sensitive glycoprotein (Hynes (1976)
Biochim. biophys. Act(', 458, 73). Our finding
may relate to a similar entity in peripheral
lymphocytes.
The low levels of protease-sensitive sialic
acid in tonsillar lymphocytes and thymocytes
may reflect general surface differences be-
tween tissue-located lymphocytes and their
circulating counterparts.
STUDIES ON THE MICROCYTOTOXI-
CITY TEST: EVIDENCE THAT THE
EFFECTS OF NORMAL LYMPHOID
CELLS ON THE GROWTH AND SUR-
VIVAL OF SYNGENEIC TUMOUR
CELLS IN MICROTEST PLATES ARE
CAUSED BY NON-IMMUNOLOGICAL
MODIFICATIONS OF THE CULTURE
MEDIUM. R. C. REES and C. G. BROOKS,
Cancer Research Campaign Laboratories, Uni-
versity of Nottingham.
Despite many years of intensive research,
it is still not clear whether lymphoid cells
from human cancer patients possess any
specific cytotoxic activity towards the hosts'
tumour cells, similar to that demonstrated in
various animal systems. The major problem
has been the high, but variable, " non-
specific " cytotoxic activity of leucocytes
obtained from control patients. To try to
elucidate the mechanisms of this " non-
specific" killing, we have studied what
appears to be a similar phenomenon in inbred
rats. Thus, lymph node cells (LNC) from
normal Wistar rats were found either to
inhibit or to enhance the growth and survival
of syngeneic solid tumour cells cultured in
micro-test plates. Which effect was observed
depended on the particular tumour cell used
and, in some cases, on the particular in vitro
subline used. The cells responsible forinhibi-
tion were selectively retained on nylon-wool
columns, whereas the cells responsible for
enhancement were selectively eluted. When
these cell fractions were incubated in the
absence of tumour cells, the cell-free super-
natants mediated the same effects as the cells
from which they were derived. The super-
natant inhibitory activitywasmaximal within
1 h of cell culture, whereas the supernatant
enhancing activity developed over a 48-h
period. Furthermore, tumour cells them-
selves produced growth-enhancing activity
during culture in microplates. It is proposed
that interaction between these various super-
natants is responsible, at least in part, for the
non-specific effects of normal lymphoid cells
in the microcytotoxicity test.
IMMUNOLOGICAL STUDIES OF
PATIENTS WITH PRIMARY BREAST
CARCINOMA. R. A. ROBINS, C. J.
DAVIES, I. D. MEREDITH, R. W. BLAMEY and
R. W. BALDWIN, Cancer Research Campaign
Laboratories and Department of Surgery, The
University, Nottingham NG7 2RD.
Immunological tests with primary breast
carcinoma patients were undertaken, to
evaluate their usefulness in prognosis of
individual patients. General cellular im-
munocompetence was tested by response to
dinitrochlorobenzene (DNCB); sensitization
was detected both by skin testing and in vitro
leucocyte migration inhibition to DNCB.
" Specific " cellular reactivity to an extract
of pooled breast carcinoma tissue was mea-
sured in a leucocyte migration inhibition test.
Results ofthe immunological tests were com-
pared with prognosis determined by the triple
lymph node biopsy (TNB) method of Hand-
ley. Preliminary survival data indicate that
this method is giving reliable results in our
series of patients.
The ability to respond to DNCB, whether
detected by in vitro test or skin test, did not
correlate with prognosis determined by TNB;
indeed the best correlate of DNCB unrespon-
siveness was patients' age.
Responses to breast carcinoma extract
were detected, using breast carcinoma
patients' leucocytes at concentrations giving
low reactivity in controls. No correlation
between reactivity and TNB prognosis has so
far been observed.
K-CASEIN CONCENTRATIONS IN
PATIENTS WITH BENIGN AND
MALIGNANT BREAST DISEASES. R.
L. WOODS, F. S. SEARLE and K. D. BAG-
SHAWE, Department of Medical Oncology,
Charing Cross Hospttal, Fulham Palace Road,
London W6 8RF.
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A radioimmunoassaywas set up for the
breast protein K-casein. Of 361 samples
from healthy volunteers and from patients
with non-malignant diseases, only 7 gave
values greater than 60ng/ml. Sixty-two
samples from lactating women gave values
ranging from 136 ng/ml to 1700 ng/ml.
A number of samples from patients with
breast diseases were assayed: 57% ofpatients
with metastatic breast cancer had concentra-
tions more than 60 ng/ml, whilst 39% of
patients with cancer confined to the breast
and its regional nodes had elevated values.
Of those patients with treated breast cancer
but clinically tumour-free at the time of
assay, 17% had elevated concentrations.
Nine per cent of patients with histologically
proven benign breast disease had values
greater than 60 ng/ml.
No correlation was found between age,
endocrine status or histological type and
casein levels.
A radioimmunoassay for oA-lactalbumin
showed elevated concentrations in only 1/70
samples assayed from patients with proven
carcinoma of the breast.
CYTOTOXICITY OF SUBPOPULA-
TIONS OF IMMUNE LYMPHOID
CELLS, ANDANTIBODY-DEPENDENT
CELLULARCYTOTOXICITYAGAINST
GUINEA-PIG HEPATOMA CELLS IN
VITRO. M. ANDJARGHOLI and M. M. DALE,
Department of Pathobiology, Institute of
Public Health Research, University ofTeheran,
P.O. Box 1310, Teheran, Iran, and Depart-
ment of Pharmacology, University College,
London WC1.
A microassay was used for measuring the
cytotoxicity of guinea-pig lymphoid cells
against allogeneic tumour cells in culture.
The activity ofsubpopulations ofimmune
lymphocytes was investigated. From the
results obtained, it appeared that although
both T-cell-enriched and B-cell-enriched cell
populations exhibit cytotoxicity in our
tumour system, the crude cell population is
the most effective of all. This probably
suggests that there is cell cooperation in
producing cytotoxicity in this system.
Antibody-dependent cellular cytotoxicity
was also investigated in this system. It was
found that, under optimum conditions, this
type of cytotoxicity could be obtained con-
comitantly with direct cell-mediated cyto-
toxicity. A B-cell-enriched population of
normal cells was shown to become cytotoxic
to tumour cells in the presence of a high
dilution of serum from immune animals.
THE IDENTIFICATION OF INFIL-
TRATING HOST CELL TYPES IN RAT
TUMOURS OF VARYING IMMUNO-
GENICITY. K. MOORE and M. MOORE,
Paterson Laboratories, Christie Hospital and
Holt Radiumn Institute, Manchester M20 9BX.
The numbers of host infiltrating cells
found in enzyme-disaggregated rat tumours
has been measured by the formation of ery-
throcyte-antibody (EA) rosettes to detect Fc-
receptor-bearing cells, erythrocyte antibody
complement (EAC) rosettes to detect cells
bearing 3C receptors, and macrophages
identified by their ability to phagocytose
bound EA and polystyrene particles. Other
cell types were identified morphologically in
stained cytocentrifuge preparations.
Serially transplanted tumours of high
immunogenicity (MC40A, MC57) were found
to contain a greater proportion of macro-
phages (12.2 ± 0 5% and 15-2 ± 1.7% re-
spectively) than those oflow immunogenicity
(SPI, SP22, AAF57: 9-7 ± 1.4%, 85 ± 2.2%
and 4-7 ± 1.1% respectively). Also the
immunogenic tumours contained relatively
high numbers of non-phagocytic EA rosette-
forming cells (14.1% and 13.9%) compared
with the negligible numbers found in the
tumours of low immunogenicity (2 4%, 3 1%
and 0-3%). None of the tumours contained
more than 2.5% ofEAC rosette-forming cells,
polymorphonuclear leucocytes, or basophils.
The kinetics of infiltration of tumours
derived from an inoculum of 106 tumour cells
which had been depleted of host cells by a
number of in vitro passages were measured.
Initially, an increase in the number of macro-
phages relative to that found in the trans-
planted tumours was detected in immuno-
genic and non-immunogenic tumours, follow-
ed by a decline to the levels found in the
transplanted tumours. A marked difference
was the total absence of non-phagocytic EA
rosette-forming cells in one non-immuno-
genic tumour (SP22) throughout the time
course, compared with the increase of these
cells with time in the immunogenic tumour
(MC40A).
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RESPONSE OF ASTROCYTOMA
CULTURES TO THERAPEUTIC CON-
CENTRATIONS OF DEXAMETHA-
SONE AND BETAMETHASONE. M.
GUNER, R. I. FRESHNEY, D. MORGAN, M. G.
FRESHNEY and D. G. T. THOMAS, Beatson
Institute and Institute of Neuroscience,
Glasgow.
The use of steroids in the management of
patients with brain tumours has raised the
question whether these drugs may be cyto-
toxic to the tumour cells. This has been
examined at the cellular level in cultures pre-
pared by collagenase digestion of biopsy
specimens of 1 intermediate and 4 anaplastic
astrocytomas. Secondary cultures were
shown to be predominantly aneuploid (hypo-
diploid) and proliferative (88-97% labelling
index with [3H]thymidine). They were
trypsinized, and clonal growth was measured
in the presence and absence of different
concentrations of dexamethasone and beta-
methasone. The cloning efficiencies of con-
trol cultures varied from 2-8 to 10-6% in
Ham's F12 medium supplemented with
Eagle's MEM amino acids and 20% foetal
bovine serum, buffered in 20 mm Hepes and
with no additional CO2 in the gas phase.
Stimulation ofcloning efficiency was obtained
in every case (5 cell lines, 6 experiments)
reaching a maximum at 12-5 ,ug/ml with both
steroids. The percentage stimulation varied
from 50% to 250%, and toxicity was only
produced at 50 jug/ml in most cases. Dexa-
methasone was generally found to be more
toxic than betamethasone. Analysis of
colony size (cells/colony) showed a similar
pattern, with maximum stimulation of
colony size at 12-5 ,tg/ml of either steroid.
Similar clonal cultures from an acromegalic
pituitary tumour showed 2-3 times higher
cloning efficiency in dexamethasone, but
reduced colony size at 125 jug/ml. A similar
effect was also found with normal diploid
fibroblasts. So far, only astrocytoma cul-
tures have shown increased proliferation in
dexamethasone or betamethasone, and only
in conditions of low C02 and bicarbonate
concentration.
Under these particular conditions, dexa-
methasone and betamethasone promote clonal
growthin astrocytoma cultures, and arefound
to be cytotoxic only at concentrations un-
likely to be found in vivo. It is now intended
to test the effects of these steroids at higher
cell densities, and in vivo, to determine the
potential clinical relevance of these findings.
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